NASDAQ:EAR

Eargo Stock Forecast, Price & News

$21.97
+0.20 (+0.92 %)
(As of 09/17/2021 04:00 PM ET)
Add
Compare
Today's Range
$21.53
$22.72
50-Day Range
$19.90
$37.14
52-Week Range
$19.25
$76.75
Volume1.03 million shs
Average Volume724,320 shs
Market Capitalization$860.35 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive EAR News and Ratings via Email

Sign-up to receive the latest news and ratings for Eargo and its competitors with MarketBeat's FREE daily newsletter.


Eargo logo

About Eargo

Eargo, Inc., a medical device company, develops and sells hearing aids to assist people with hearing loss in the United States. It sells its products through online stores. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was founded in 2010 and is headquartered in San Jose, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.28 out of 5 stars

Medical Sector

264th out of 1,350 stocks

Surgical Appliances & Supplies Industry

8th out of 26 stocks

Analyst Opinion: 3.5Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Eargo (NASDAQ:EAR) Frequently Asked Questions

Is Eargo a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Eargo in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Eargo stock.
View analyst ratings for Eargo
or view top-rated stocks.

What stocks does MarketBeat like better than Eargo?

Wall Street analysts have given Eargo a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Eargo wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Eargo's next earnings date?

Eargo is scheduled to release its next quarterly earnings announcement on Thursday, November 18th 2021.
View our earnings forecast for Eargo
.

How were Eargo's earnings last quarter?

Eargo, Inc. (NASDAQ:EAR) announced its quarterly earnings data on Thursday, August, 12th. The company reported ($0.36) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.25) by $0.11. Eargo had a negative trailing twelve-month return on equity of 39.32% and a negative net margin of 52.33%.
View Eargo's earnings history
.

What guidance has Eargo issued on next quarter's earnings?

Eargo issued an update on its FY 2021 earnings guidance on Thursday, September, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $93 million-$96 million, compared to the consensus revenue estimate of $91.97 million.

What price target have analysts set for EAR?

4 equities research analysts have issued 1-year price objectives for Eargo's stock. Their forecasts range from $41.00 to $52.00. On average, they anticipate Eargo's share price to reach $45.33 in the next year. This suggests a possible upside of 106.3% from the stock's current price.
View analysts' price targets for Eargo
or view top-rated stocks among Wall Street analysts.

Who are Eargo's key executives?

Eargo's management team includes the following people:
  • Mr. Christian Gormsen, CEO, Pres & Director (Age 45, Pay $662.17k)
  • Mr. Adam Laponis, Chief Financial Officer (Age 45, Pay $398.5k) (LinkedIn Profile)
  • Mr. William H. Brownie, Chief Operating Officer (Age 54, Pay $398.5k)
  • Mr. Daniel Shen, Co-Founder and Chief Clinical & Science Officer
  • Mr. Fernando Cruz, Chief Information Officer
  • Mr. Nicholas S. Laudico, VP of Investor Relations
  • Ms. Christy La Pierre, Chief Legal Officer & Sec.
  • Ms. Tricia Burchell, VP of People Operations
  • Mr. Michael Perry, Sr. VP of Engineering

Who are some of Eargo's key competitors?

When did Eargo IPO?

(EAR) raised $100 million in an initial public offering (IPO) on Friday, October 16th 2020. The company issued 6,700,000 shares at $14.00-$16.00 per share. J.P.Morgan and BofA Securities served as the underwriters for the IPO and Wells Fargo Securities and William Blair were co-managers.

What is Eargo's stock symbol?

Eargo trades on the NASDAQ under the ticker symbol "EAR."

Who are Eargo's major shareholders?

Eargo's stock is owned by a variety of retail and institutional investors. Top institutional investors include NEA Management Company LLC (11.67%), BlackRock Inc. (8.30%), Vanguard Group Inc. (4.26%), Alliancebernstein L.P. (3.63%), Millennium Management LLC (2.74%) and Victory Capital Management Inc. (2.42%). Company insiders that own Eargo stock include Adam Laponis, Geoff Pardo, Healthcare Holding BV Gilde, Mohamad Makhzoumi and Nina Richardson.
View institutional ownership trends for Eargo
.

Which major investors are selling Eargo stock?

EAR stock was sold by a variety of institutional investors in the last quarter, including NEA Management Company LLC, Invesco Ltd., Wells Fargo & Company MN, Marshall Wace LLP, Marshall Wace LLP, Marshall Wace North America L.P., Russell Investments Group Ltd., and Osterweis Capital Management Inc.. Company insiders that have sold Eargo company stock in the last year include Adam Laponis, Geoff Pardo, Healthcare Holding BV Gilde, Mohamad Makhzoumi, and Nina Richardson.
View insider buying and selling activity for Eargo
or view top insider-selling stocks.

Which major investors are buying Eargo stock?

EAR stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Millennium Management LLC, Vanguard Group Inc., Victory Capital Management Inc., Morgan Stanley, Morgan Stanley, State Street Corp, and Capital International Investors.
View insider buying and selling activity for Eargo
or or view top insider-buying stocks.

How do I buy shares of Eargo?

Shares of EAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eargo's stock price today?

One share of EAR stock can currently be purchased for approximately $21.97.

How much money does Eargo make?

Eargo has a market capitalization of $860.35 million and generates $69.15 million in revenue each year. The company earns $-39,850,000.00 in net income (profit) each year or ($3.80) on an earnings per share basis.

How many employees does Eargo have?

Eargo employs 238 workers across the globe.

What is Eargo's official website?

The official website for Eargo is eargo.com.

How can I contact Eargo?

The company can be reached via phone at 650-351-7700 or via email at [email protected].


This page was last updated on 9/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.